Please use this identifier to cite or link to this item:
https://ir.swu.ac.th/jspui/handle/123456789/13782
Full metadata record
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Pingaew R. | |
dc.contributor.author | Prachayasittikul V. | |
dc.contributor.author | Mandi P. | |
dc.contributor.author | Nantasenamat C. | |
dc.contributor.author | Prachayasittikul S. | |
dc.contributor.author | Ruchirawat S. | |
dc.contributor.author | Prachayasittikul V. | |
dc.date.accessioned | 2021-04-05T03:26:28Z | - |
dc.date.available | 2021-04-05T03:26:28Z | - |
dc.date.issued | 2015 | |
dc.identifier.issn | 9680896 | |
dc.identifier.other | 2-s2.0-84937425435 | |
dc.identifier.uri | https://ir.swu.ac.th/jspui/handle/123456789/13782 | - |
dc.identifier.uri | https://www.scopus.com/inward/record.uri?eid=2-s2.0-84937425435&doi=10.1016%2fj.bmc.2015.04.036&partnerID=40&md5=ded6150540b91998db68cccbfd84b0e8 | |
dc.description.abstract | Abstract A series of 1,4-disubstituted-1,2,3-triazoles (13-35) containing sulfonamide moiety were synthesized and evaluated for their aromatase inhibitory effects. Most triazoles with open-chain sulfonamide showed significant aromatase inhibitory activity (IC50 = 1.3-9.4 μM). Interestingly, the meta analog of triazole-benzene-sulfonamide (34) bearing 6,7-dimethoxy substituents on the isoquinoline ring displayed the most potent aromatase inhibitory activity (IC50 = 0.2 μM) without affecting normal cell. Molecular docking of these triazoles against aromatase revealed that the compounds could snugly occupy the active site of the enzyme through hydrophobic, π-π stacking, and hydrogen bonding interactions. The potent compound 34 was able to form hydrogen bonds with Met374 and Ser478 which were suggested to be the essential residues for the promising inhibition. The study provides compound 34 as a potential lead molecule of anti-aromatase agent for further development. © 2015 Elsevier Ltd. | |
dc.subject | 1,2,3 triazole derivative | |
dc.subject | 1,2,3 triazole sulfonamide derivative | |
dc.subject | 4 [[1 [3 [(3,4 dihydroisoquinolin 2 (1h)yl)sulfonyl]phenyl] 1h 1,2,3 triazol 4 yl]methoxy] 2h chromen 2 one | |
dc.subject | 4 [[1 [3 [(6,7 dimethoxy 3,4 dihydroisoquinolin 2 (1h)yl)sulfonyl]phenyl] 1h 1,2,3 triazol 4 yl]methoxy] 2h chromen 2 one | |
dc.subject | 7 [[1 [3 [(3,4 dihydroisoquinolin 2 (1h)yl)sulfonyl]phenyl] 1h 1,2,3 triazol 4 yl]methoxy] 2h chromen 2 one | |
dc.subject | 7 [[1 [3 [(6,7 dimethoxy 3,4 dihydroisoquinolin 2 (1h)yl)sulfonyl]phenyl] 1h 1,2,3 triazol 4 yl]methoxy] 2h chromen 2 one | |
dc.subject | aromatase inhibitor | |
dc.subject | coumarin oxymethyl | |
dc.subject | functional group | |
dc.subject | ketoconazole | |
dc.subject | letrozole | |
dc.subject | naphthalene oxymethyl | |
dc.subject | phenoxymethyl | |
dc.subject | phenyl group | |
dc.subject | sulfonamide | |
dc.subject | sulfonyl group | |
dc.subject | unclassified drug | |
dc.subject | antineoplastic agent | |
dc.subject | aromatase | |
dc.subject | aromatase inhibitor | |
dc.subject | CYP19A1 protein, human | |
dc.subject | isoquinoline derivative | |
dc.subject | protein binding | |
dc.subject | sulfonamide | |
dc.subject | triazole derivative | |
dc.subject | animal cell | |
dc.subject | Article | |
dc.subject | binding affinity | |
dc.subject | binding site | |
dc.subject | carbon nuclear magnetic resonance | |
dc.subject | chemical interaction | |
dc.subject | chemical reaction | |
dc.subject | Click reaction | |
dc.subject | concentration response | |
dc.subject | controlled study | |
dc.subject | drug cytotoxicity | |
dc.subject | drug mechanism | |
dc.subject | drug potency | |
dc.subject | drug safety | |
dc.subject | drug screening | |
dc.subject | drug synthesis | |
dc.subject | enzyme active site | |
dc.subject | enzyme inhibition | |
dc.subject | hydrogen bond | |
dc.subject | hydrophobicity | |
dc.subject | IC50 | |
dc.subject | mass spectrometry | |
dc.subject | molecular docking | |
dc.subject | nonhuman | |
dc.subject | pi pi stacking interaction | |
dc.subject | proton nuclear magnetic resonance | |
dc.subject | structure activity relation | |
dc.subject | Vero cell line | |
dc.subject | animal | |
dc.subject | cell survival | |
dc.subject | chemical phenomena | |
dc.subject | chemistry | |
dc.subject | Chlorocebus aethiops | |
dc.subject | drug effects | |
dc.subject | human | |
dc.subject | synthesis | |
dc.subject | Animals | |
dc.subject | Antineoplastic Agents | |
dc.subject | Aromatase | |
dc.subject | Aromatase Inhibitors | |
dc.subject | Catalytic Domain | |
dc.subject | Cell Survival | |
dc.subject | Cercopithecus aethiops | |
dc.subject | Humans | |
dc.subject | Hydrogen Bonding | |
dc.subject | Hydrophobic and Hydrophilic Interactions | |
dc.subject | Isoquinolines | |
dc.subject | Molecular Docking Simulation | |
dc.subject | Protein Binding | |
dc.subject | Structure-Activity Relationship | |
dc.subject | Sulfonamides | |
dc.subject | Triazoles | |
dc.subject | Vero Cells | |
dc.title | Synthesis and molecular docking of 1,2,3-triazole-based sulfonamides as aromatase inhibitors | |
dc.type | Article | |
dc.rights.holder | Scopus | |
dc.identifier.bibliograpycitation | Bioorganic and Medicinal Chemistry. Vol 23, No.13 (2015), p.3472-3480 | |
dc.identifier.doi | 10.1016/j.bmc.2015.04.036 | |
Appears in Collections: | Scopus 1983-2021 |
Files in This Item:
There are no files associated with this item.
Items in SWU repository are protected by copyright, with all rights reserved, unless otherwise indicated.